Notably, our previous study showed that the interaction of microseminoprotein (MSMP), a CCR2 ligand, with CCR2 plays an important role in promoting adaptive resistance to AVA in ovarian cancer models (Mitamura et al. 2018). This evidence concerns the gene CCR2 and ovarian cancer.